Chemoinformaics analysis of 10-Acetoxy-1-homovaltrate hydrin
| Molecular Weight | 496.553 | nRot | 11 |
| Heavy Atom Molecular Weight | 460.265 | nRig | 14 |
| Exact Molecular Weight | 496.231 | nRing | 2 |
| Solubility: LogS | -3.913 | nHRing | 1 |
| Solubility: LogP | 3.314 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 73.7746 |
| nHD | 1 | BPOL | 48.2675 |
| QED | 0.336 |
| Synth | 4.828 |
| Natural Product Likeliness | 2.307 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.998 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.646 |
| MDCK | 0.0000517 |
| BBB | 0.896 |
| PPB | 0.591157 |
| VDSS | 1.242 |
| FU | 0.268888 |
| CYP1A2-inh | 0.106 |
| CYP1A2-sub | 0.031 |
| CYP2c19-inh | 0.126 |
| CYP2c19-sub | 0.074 |
| CYP2c9-inh | 0.554 |
| CYP2c9-sub | 0.02 |
| CYP2d6-inh | 0.331 |
| CYP2d6-sub | 0.023 |
| CYP3a4-inh | 0.549 |
| CYP3a4-sub | 0.266 |
| CL | 3.935 |
| T12 | 0.538 |
| hERG | 0.208 |
| Ames | 0.994 |
| ROA | 0.786 |
| SkinSen | 0.952 |
| Carcinogencity | 0.935 |
| EI | 0.042 |
| Respiratory | 0.902 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.9304 |